(firstQuint)Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT.

 This pharmacokinetic profile will be obtained in only in patient using Advate(R) (human Factor VIII) with myPKFiT(R).

 This patients will be followed during the period of 12 months, and the pharmacokinetic will be measured collecting 2 blood samples, in which the presence of Factor VIII will be determined by the usual clinical methods: chromogenic method or coagulative method.

.

 Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT@highlight

The purpose of this study is to describe the pharmacokinetic profile of patients with hemophilia A in prophylaxis in Spain using myPKFit(R)